TruScreen Limited TruScreen 2017 Annual Shareholders Meeting – Voting Results
TruScreen Limited (NZAX: TRU)
Details of the results of the resolutions proposed at the TruScreen Annual Meeting of shareholders on September 21, 2017 were:
1. Re-election of Director – Mr Tim Preston retires in accordance with the provisions of the Constitution of the Company and, being eligible, offers himself for re- election. RESULT: Mr Preston withdrew his nomination and the resolution was not put to the meeting.
2. Appointment and Remuneration of Auditors – That BDO Auckland be appointed as Auditors of the Company under section 200 of the Companies Act, and to authorise the Board to fix their remuneration for the forthcoming year. RESULT: Passed by unanimous vote of both the shareholders present at the meeting and the proxies registered.
The Board has determined that in accordance with the NZAX listing rule 3.2.1, one director, Sean Joyce, is ordinarily resident in New Zealand.
The TruScreen Board will meet as soon as is practicable to fill the vacancy created by the retirement of Mr Preston.
Contact Martin Dillon
TruScreen Chief Executive Officer
TruScreen’s real time cervical cancer technology utilises a digital wand which is placed on the surface of the cervix to measure electrical and optical signals from the surrounding tissue. A sophisticated proprietary algorithm framework distinguishes between normal and abnormal (cancerous and precancerous) tissue to identify precancerous change, or cervical intraepithelial neoplasia (CIN). A Single Use Sensor (SUS) is used for each patient to protect against cross-infection.